Clarifying the novelty of TLR4-targeted therapy in lung ischemia-reperfusion injury. // JHLT Open. – URL: https://www.sciencedirect.com/science/article/pii/S2950133426002211?dgcid=rss_sd_all
Clarifying the novelty of TLR4-targeted therapy in lung ischemia-reperfusion injury. JHLT Open. https://www.sciencedirect.com/science/article/pii/S2950133426002211?dgcid=rss_sd_all
“Clarifying the novelty of TLR4-targeted therapy in lung ischemia-reperfusion injury.” JHLT Open.
@article{article51266,
title = {Clarifying the novelty of TLR4-targeted therapy in lung ischemia-reperfusion injury},
journal = {JHLT Open},
url = {https://www.sciencedirect.com/science/article/pii/S2950133426002211?dgcid=rss_sd_all}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...